Study guide

3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation

Veterinary Technician Specialist in Emergency and Critical Care VTS ECC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Triage & Point-of-Care Assessment

1.1 AVECCTN Examination Structure, Blueprint & Credentialing 1.2 Emergency Triage Systems, Primary Survey & Capsule Diagnostics 1.3 Point-of-Care Ultrasound (POCUS / TFAST / AFAST / VetBLUE) & Rapid Interventions

2 Chapter 2: Cardiovascular Emergencies & RECOVER CPR

2.1 RECOVER Guidelines: Basic Life Support (BLS) & Resuscitation Dynamics 2.2 Advanced Life Support (ALS): Emergency Pharmacopeia, Reversals & Defibrillation 2.3 Electrocardiogram (ECG) Interpretation & Antiarrhythmic Therapy 2.4 Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism

3 Chapter 3: Fluid Therapy, Shock Resuscitation & Acid-Base Balance

3.1 Pathophysiology, Stages & Classification of Shock 3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation 3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus 3.4 Arterial & Venous Blood Gas Analysis & Acid-Base Disorders

4 Chapter 4: Respiratory Emergencies & Mechanical Ventilation

4.1 Upper Airway Obstruction: BOAS, Laryngeal Paralysis & Tracheal Collapse 4.2 Lower Airway, Pulmonary Parenchymal & Vascular Emergencies: Asthma, Contusions & ARDS 4.3 Pleural Space Disease, Emergency Thoracocentesis & Chest Tube Management 4.4 Oxygen Delivery Modalities, Capnography & Mechanical Ventilation Basics

5 Chapter 5: Gastrointestinal & Hepatic Emergencies

5.1 Gastric Dilatation-Volvulus (GDV): Resuscitation, Decompression & Critical Nursing 5.2 Acute Abdomen, Septic Peritonitis & Canine Parvoviral Enteritis 5.3 Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus 5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies

6 Chapter 6: Anesthesia, Analgesia & Constant Rate Infusions

6.1 Emergency Anesthesia Protocols & High-Risk Patient Stabilization 6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia 6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring 6.4 Anesthetic Complications: Hypotension, Hypothermia & Emergency Interventions

7 Chapter 7: Renal & Urinary Emergencies

7.1 Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy 7.2 Feline Urethral Obstruction: Deobstruction, Electrolyte Crises & Post-Obstructive Diuresis 7.3 Uroabdomen & Lower Urinary Tract Trauma: Diagnosis & Resuscitation

8 Chapter 8: Hemolymphatic, Transfusion Medicine & Sepsis/SIRS

8.1 Transfusion Medicine: Blood Typing, Crossmatching & Component Therapy 8.2 Immune-Mediated Hemolytic Anemia (IMHA) & Immune-Mediated Thrombocytopenia (IMTP) 8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC 8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia

9 Chapter 9: Environmental, Toxicological, Ophthalmic & Exotic Species Emergencies

9.1 Heatstroke, Severe Hypothermia & Thermal Burn Management 9.2 Envenomation Syndromes & Acute Anaphylaxis Management 9.3 Common Small Animal Toxicities: Chocolate, Xylitol, NSAIDs & Rodenticides 9.4 Neurotoxins, Ethylene Glycol, Plant Toxins & Extracorporeal Therapies 9.5 Ophthalmologic Emergencies: Proptosis, Acute Glaucoma, Corneal Perforation & Chemical Injury 9.6 Emergency Care of Exotic Companion Species: Rabbits, Rodents, Ferrets, Birds & Reptiles

10 Chapter 10: Neurological Emergencies

10.1 Status Epilepticus & Cluster Seizures: Emergency Protocols & Refractory Therapy 10.2 Traumatic Brain Injury (TBI), Intracranial Pressure (ICP) & Modified Glasgow Coma Scale 10.3 Acute Spinal Cord Emergencies: Intervertebral Disc Disease (IVDD) & Neuro-Localization

11 Chapter 11: Endocrine & Metabolic Crises

11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Acute Adrenocortical Crisis (Addisonian Crisis) & Hypoadrenocorticism 11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia

12 Chapter 12: Reproductive & Musculoskeletal Emergencies

12.1 Reproductive Emergencies: Dystocia, Pyometra & Puerperal Hypocalcemia 12.2 Musculoskeletal Trauma: Open Fractures, Luxations, Splints & Compartment Syndrome 12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation

13 Chapter 13: Advanced Critical Care Monitoring, Vascular Access & The Rule of 20

13.1 Central Venous Catheterization, Arterial Lines & Intraosseous Access 13.2 Hemodynamic Monitoring: Invasive vs. Non-Invasive Blood Pressure, CVP & Cardiac Output 13.3 Kirby's Rule of 20: Comprehensive Daily Critical Patient Evaluation Checklist

3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation

Key Takeaways Explain This Topic AI

Total body water comprises 60% of body weight (40% ICF, 20% ECF divided into 15% ISF and 5% IVF); isotonic crystalloids rapidly redistribute across the ECF, leaving only 20-25% in the intravascular space after 30-60 minutes.

The Revised Starling Model demonstrates that the endothelial glycocalyx layer (EGL) governs fluid transudation; indiscriminate rapid fluid bolusing degrades the glycocalyx and accelerates interstitial edema.

Shock fluid resuscitation must be administered in fractionated aliquots (1/4 to 1/3 of total blood volume: 15-20 mL/kg in dogs, 10-15 mL/kg in cats over 15-20 minutes) with patient reassessment between aliquots.

Hypertonic saline (7.2-7.5% NaCl at 3-5 mL/kg slow IV over 10-15 min) rapidly expands intravascular volume by 2-4x infused volume via osmotic mobilization of interstitial fluid, indicated for TBI, massive hypovolemia, and GDV, but contraindicated in dehydration or hypernatremia.

Total fluid replacement requires calculating dehydration deficit (Deficit = % Dehydration × BW in kg × 1000 mL) administered over 12-24 hours, plus maintenance (60 mL/kg/day or 132 × BW^0.75) and volume-for-volume replacement of ongoing losses.

Last updated: August 2026

Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation

VTS Core Concept: Intravenous fluid therapy is a potent pharmacological intervention. Every fluid type possesses specific tonicity, electrolyte composition, buffering capacity, and distribution kinetics. Selecting the incorrect fluid, volume, or infusion rate can precipitate life-threatening cellular edema, hyperchloremic acidemia, acute coagulopathy, or cardiovascular collapse.

  • 1. Fluid Compartments & The Revised Starling Principle
  • The 60-40-20 Rule of Body Fluid Distribution

In healthy adult dogs and cats, Total Body Water (TBW) accounts for approximately 60% of total body weight ( 600 mL/kg 600\text{ mL/kg} 600 mL/kg ). +--------------------------------------------------------------------------+

  • | TOTAL BODY WATER (60% BW) |
  • +------------------------------------+-------------------------------------+
  • | INTRACELLULAR FLUID (ICF) | EXTRACELLULAR FLUID (ECF) |
  • | 40% of BW | 20% of BW |
  • | (2/3 of TBW) | (1/3 of TBW) |
  • | +------------------+------------------+
  • | | Interstitial | Intravascular |
  • | | Fluid (ISF) | Fluid (IVF) |
  • | | 15% of BW | 5% of BW |
  • | | (3/4 of ECF) | (1/4 of ECF) |
  • +------------------------------------+------------------+------------------+

Intravascular Blood Volume:

Canine: ≈ 80 − 90 mL/kg \approx 80-90\text{ mL/kg} ≈ 80 − 90 mL/kg total blood volume (plasma constitutes ≈ 50 − 55 mL/kg \approx 50-55\text{ mL/kg} ≈ 50 − 55 mL/kg ).

Feline: ≈ 45 − 60 mL/kg \approx 45-60\text{ mL/kg} ≈ 45 − 60 mL/kg total blood volume (plasma constitutes ≈ 30 − 35 mL/kg \approx 30-35\text{ mL/kg} ≈ 30 − 35 mL/kg ).

The Endothelial Glycocalyx & Revised Starling Model

Historically, the classical Starling principle assumed continuous transcapillary filtration at the arterial end and significant venous reabsorption driven by plasma colloid osmotic pressure (COP). Modern microvascular physiology has revised this model:

The Endothelial Glycocalyx Layer (EGL): A complex, 0.5 − 3.0 μ m 0.5-3.0\;\mu\text{m} 0.5 − 3.0 μ m thick, negatively charged meshwork of proteoglycans (syndecans, glypicans), glycosaminoglycans (heparan sulfate, chondroitin sulfate, hyaluronan), and adsorbed plasma proteins (albumin, antithrombin) coating the luminal vascular endothelium.

The Non-Reabsorption Phenomenon: In most continuous capillaries, filtration occurs throughout the length of the capillary bed at varying rates; there is virtually no fluid reabsorption into the venous end of the capillary bed . Filtered interstitial fluid is cleared almost exclusively by the lymphatic system .

Glycocalyx Degradation (Shedding): Ischemia-reperfusion injury, endotoxemia, sepsis, severe trauma, hypernatremia, and rapid, excessive isotonic crystalloid bolusing (which triggers atrial natriuretic peptide [ANP] release) degrade and shed the glycocalyx. Shedding destroys the semipermeable oncotic barrier, drastically increasing microvascular permeability and precipitating severe extravasation of albumin and water into tissues (edema formation).

2. Crystalloid Solutions: Balanced vs. Unbalanced

Crystalloids are aqueous solutions of mineral salts and water-soluble molecules with small molecular weights ( < 30 kDa < 30\text{ kDa} < 30 kDa ) that pass freely across semipermeable capillary membranes.

Isotonic Replacement Crystalloid Comparison

Solution N a + Na^+ N a + (mEq/L) K + K^+ K + (mEq/L) C l − Cl^- C l − (mEq/L) C a 2 + Ca^{2+} C a 2 + (mEq/L) M g 2 + Mg^{2+} M g 2 + (mEq/L) Buffer (mEq/L) Osmolarity (mOsm/L) In-Vitro pH

Plasma (Canine) 140-155 3.5-5.5 105-120 4.5-5.5 1.5-2.5 H C O 3 − HCO_3^- H C O 3 − ​ (18-24) 290-310 7.35-7.45

  • Normosol-R / Plasmalyte-148 140 5 98 0 3 Acetate (27) + Gluconate (23) 294-295 7.4
  • Lactated Ringer's (LRS) 130 4 109 3 0 L-Lactate (28) 273 6.5
  • 0.9% NaCl (Normal Saline) 154 0 154 0 0 None (0) 308 5.5
  • Clinical Distinctions and Safety Considerations

Distribution Kinetics: Because sodium distributes freely throughout the extracellular fluid compartment ( 75 % ISF 75\%\text{ ISF} 75% ISF vs. 25 % IVF 25\%\text{ IVF} 25% IVF ), only 20% to 25% of an infused isotonic crystalloid bolus remains within the intravascular space 30 to 60 minutes post-infusion . The remaining 75 − 80 % 75-80\% 75 − 80% redistributes into the interstitial space.

0.9% Normal Saline Risks: Normal saline contains a supra-physiological chloride concentration ( 154 mEq/L 154\text{ mEq/L} 154 mEq/L vs. normal plasma 110 mEq/L 110\text{ mEq/L} 110 mEq/L ) and an effective Strong Ion Difference ( S I D SID S I D ) of zero. Rapid administration causes hyperchloremic metabolic acidosis and renal vasoconstriction with decreased GFR. Indications are strictly limited to: hypochloremic metabolic alkalosis (upper GI obstruction/vomiting), hypercalcemia (promotes renal calcium excretion), and Addisonian crisis.

Calcium in LRS: LRS contains 3 mEq/L C a 2 + 3\text{ mEq/L } Ca^{2+} 3 mEq/L C a 2 + . It must never be co-administered in the same IV line with blood products containing citrate anticoagulants (e.g., Packed Red Blood Cells, Fresh Frozen Plasma); ionized calcium binds citrate, reversing anticoagulation and precipitating lethal microthrombi.

3. Shock Fluid Dosing & The Fractionated Bolus Strategy

Traditional "full shock doses" represent an estimate of the patient's entire circulating blood volume:

  • Canine Full Shock Volume: 80 − 90 mL/kg 80-90\text{ mL/kg} 80 − 90 mL/kg
  • Feline Full Shock Volume: 45 − 60 mL/kg 45-60\text{ mL/kg} 45 − 60 mL/kg
  • 🛑 Critical Modern Standard: The Fractionated Aliquot Approach

Never administer a full calculated shock dose as an open, continuous infusion. Full shock doses lead to severe volume overload, tissue edema, abdominal compartment syndrome, glycocalyx destruction, and dilution of clotting factors and red cell mass.

The Protocol:

Administer 1 / 4 to 1 / 3 1/4\text{ to } 1/3 1/4 to 1/3 of the calculated shock volume over 15 − 20 minutes 15-20\text{ minutes} 15 − 20 minutes :

  • Dogs: 15 − 25 mL/kg 15-25\text{ mL/kg} 15 − 25 mL/kg isotonic balanced crystalloid IV
  • Cats: 10 − 15 mL/kg 10-15\text{ mL/kg} 10 − 15 mL/kg isotonic balanced crystalloid IV

Pause the infusion and perform an immediate focused physical reassessment :

Mentation, HR, pulse quality, CRT, MM color, blood pressure (MAP > 65 mmHg > 65\text{ mmHg} > 65 mmHg ), blood lactate clearance, and point-of-care lung ultrasound (TFAST/Vet BLUE for B-lines).

If endpoints are achieved: Stop shock bolusing and transition to calculated rehydration/maintenance rates.

If hypoperfusion persists and no fluid intolerance (pulmonary crackles, B-lines, gallop rhythm) is detected: Administer a second fractionated aliquot ( 10 − 15 mL/kg 10-15\text{ mL/kg} 10 − 15 mL/kg in dogs, 5 − 10 mL/kg 5-10\text{ mL/kg} 5 − 10 mL/kg in cats).

4. Hypertonic Saline (7.2% - 7.5% NaCl)

Hypertonic Saline (HTS) is an intensely concentrated crystalloid solution ( 2400 − 2560 mOsm/L 2400-2560\text{ mOsm/L} 2400 − 2560 mOsm/L , ≈ 8 × \approx 8\times ≈ 8 × physiological osmolarity).

Dose: 3 − 5 mL/kg 3-5\text{ mL/kg} 3 − 5 mL/kg slow IV over 10 − 15 minutes 10-15\text{ minutes} 10 − 15 minutes (dogs and cats).

Mechanism of Action: Creates a profound osmotic gradient between the intravascular and interstitial spaces. It rapidly draws endogenous water from the swollen interstitial and intracellular compartments into the vascular space, expanding circulating blood volume by 2 to 4 × 2\text{ to }4\times 2 to 4 × the infused volume (e.g., 100 mL 100\text{ mL} 100 mL HTS expands intravascular volume by 300 − 400 mL 300-400\text{ mL} 300 − 400 mL ). It also improves cardiac contractility, decreases endothelial cell swelling, and dampens neuroinflammatory cytokine cascades.

Primary Clinical Indications:

Traumatic Brain Injury (TBI): Rapidly reduces intracranial pressure (ICP) by dehydrating brain parenchyma while simultaneously restoring MAP and cerebral perfusion pressure ( C P P = M A P − I C P CPP = MAP - ICP CPP = M A P − I CP ).

Severe Hypovolemic Shock / Massive Hemorrhage: Rapid volume resuscitation when large-volume crystalloids cannot be rapidly infused.

Large-Breed Gastric Dilatation-Volvulus (GDV): Rapid resuscitation prior to emergency surgical decompression.

Contraindications & Precautions:

Dehydration: Must not be used in dehydrated patients; drawing water from an already depleted interstitium induces profound intracellular dehydration.

Hypernatremia: Strictly contraindicated if serum [ N a + ] > 160 mEq/L [Na^+] > 160\text{ mEq/L} [ N a + ] > 160 mEq/L .

Rapid Bolus Warning: Infusing HTS rapidly ( < 5 minutes < 5\text{ minutes} < 5 minutes ) triggers a vagally mediated reflex causing severe bradycardia, profound hypotension, and bronchoconstriction .

Duration: Intravascular volume expansion lasts only 30 − 60 minutes 30-60\text{ minutes} 30 − 60 minutes ; it must be followed immediately by isotonic crystalloids.

5. Colloids: Synthetic vs. Natural

Colloids are high-molecular-weight solutions ( > 30 − 40 kDa > 30-40\text{ kDa} > 30 − 40 kDa ) that remain largely confined within the intravascular space, exerting Colloid Osmotic Pressure (COP) (normal plasma COP ≈ 18 − 24 mmHg \text{COP} \approx 18-24\text{ mmHg} COP ≈ 18 − 24 mmHg ).

Synthetic Colloids: Hydroxyethyl Starches (HES)

Formulations: VetStarch, Voluven (6% HES 130/0.4 in balanced electrolyte solution).

Dosing: Dogs: 10 − 20 mL/kg/24 hr 10-20\text{ mL/kg/24 hr} 10 − 20 mL/kg/24 hr (bolus 3 − 5 mL/kg 3-5\text{ mL/kg} 3 − 5 mL/kg over 15 min 15\text{ min} 15 min ); Cats: 5 − 10 mL/kg/24 hr 5-10\text{ mL/kg/24 hr} 5 − 10 mL/kg/24 hr (bolus 2 − 3 mL/kg 2-3\text{ mL/kg} 2 − 3 mL/kg over 20 min 20\text{ min} 20 min ).

Critical Toxicities & Risks:

Acute Kidney Injury (AKI): Molecules accumulate within renal tubular epithelial cells, causing osmotic nephrosis and acute renal failure.

Coagulopathy: HES impairs primary and secondary hemostasis by coating platelets, accelerating the clearance of Factor VIII and von Willebrand Factor (vWF) (acquired type 1 von Willebrand syndrome), and impairing fibrin polymer cross-linking.

Reticuloendothelial Tissue Storage: Hydroxyethyl starch polymers cannot be metabolized by tissue enzymes and persist indefinitely within reticuloendothelial macrophages in liver, spleen, and skin (causing severe chronic pruritus).

Natural Colloids

Fresh Frozen Plasma (FFP) & Frozen Plasma (FP): Administered at 10 − 20 mL/kg 10-20\text{ mL/kg} 10 − 20 mL/kg ; provides albumin, all active clotting factors (FFP), antithrombin, and natural protease inhibitors. Indicated for coagulopathies, rodenticide toxicity, DIC, and severe pancreatitis.

Canine Serum Albumin (5% or 25%) & Human Serum Albumin (HSA): Provides concentrated oncotic support. 25% HSA carries significant risk of Type I and Type III hypersensitivity reactions (anaphylaxis and fatal immune-complex glomerulonephritis/vasculitis) in dogs; its use is strictly reserved for life-threatening hypoalbuminemia ( [ A l b ] < 1.5 g/dL [Alb] < 1.5\text{ g/dL} [ A l b ] < 1.5 g/dL ) unresponsive to other therapies.

6. Comprehensive Fluid Deficit, Maintenance & Ongoing Losses Calculations

A complete emergency fluid prescription accounts for three distinct components: Deficit + Maintenance + Ongoing Losses .

Step 1: Dehydration Deficit Calculation Fluid Deficit (mL) = % Dehydration (as decimal) × Body Weight (kg) × 1000 mL/kg \text{Fluid Deficit (mL)} = \% \text{ Dehydration (as decimal)} \times \text{Body Weight (kg)} \times 1000\text{ mL/kg} Fluid Deficit (mL) = % Dehydration (as decimal) × Body Weight (kg) × 1000 mL/kg

Clinical Estimation of Dehydration:

< 5 % < 5\% < 5% : Subclinical; no detectable physical exam abnormalities.

5 − 6 % 5-6\% 5 − 6% : Mild loss of skin turgor, slightly dry/tacky mucous membranes.

7 − 9 % 7-9\% 7 − 9% : Moderate loss of skin turgor (prolonged skin tent), tacky to dry MMs, mild enophthalmos (sunken eyes).

10 − 12 % 10-12\% 10 − 12% : Severe loss of skin turgor (persistent skin tent), completely dry/sticky MMs, marked enophthalmos, dull corneas, weak pulses, hypothermia.

≥ 13 % \ge 13\% ≥ 13% : Extreme dehydration accompanied by decompensated hypovolemic shock, moribund state.

Replacement Rate: The calculated dehydration deficit is typically replaced over 12 to 24 hours 12\text{ to }24\text{ hours} 12 to 24 hours ( 50 % 50\% 50% replaced in the first 4 − 8 hours 4-8\text{ hours} 4 − 8 hours , remainder over the subsequent 16 hours 16\text{ hours} 16 hours ).

Step 2: Maintenance Fluid Requirements

Linear Standard:

Dogs: 60 mL/kg/day 60\text{ mL/kg/day} 60 mL/kg/day (approx. 2.5 mL/kg/hr 2.5\text{ mL/kg/hr} 2.5 mL/kg/hr )

Cats: 40 − 45 mL/kg/day 40-45\text{ mL/kg/day} 40 − 45 mL/kg/day (approx. 1.7 − 2.0 mL/kg/hr 1.7-2.0\text{ mL/kg/hr} 1.7 − 2.0 mL/kg/hr )

Allometric / Exponential Formula (Gold Standard for Metabolic Accuracy):

Dogs: Maintenance (mL/day) = 132 × ( BW in kg ) 0.75 \text{Maintenance (mL/day)} = 132 \times (\text{BW in kg})^{0.75} Maintenance (mL/day) = 132 × ( BW in kg ) 0.75

Cats: Maintenance (mL/day) = 80 × ( BW in kg ) 0.75 \text{Maintenance (mL/day)} = 80 \times (\text{BW in kg})^{0.75} Maintenance (mL/day) = 80 × ( BW in kg ) 0.75

Step 3: Ongoing (Anticipated) Losses

Quantified volume-for-volume every 4 − 6 hours 4-6\text{ hours} 4 − 6 hours (vomitus, liquid diarrhea, chest tube/abdominal drain output, or polyuria in AKI/post-obstruction diuresis) using an isotonic replacement crystalloid.